ESTRO Multidisciplinary Management of Breast Cancer 2017

Conclusions (2)

Margins ?

> 0 mm

Focally involved

Macrosc. involved

Discuss with pathologist !!

• No re-excision • Boost dose only

• Re-excision • If not possible: high boost dose (EQD2 20-26 Gy)

High risk on large residual tumor volume ? NO YES

in case of other risk factors, like Young age, LVI, Grade 3, triple neg.

Boost